Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy

Clinical trial NCT05582499 · RECRUITING

Trial details

NCT number: NCT05582499
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm Breast Cancer Breast Tumors Triple-Negative Breast Cancer (TNBC)HER2-positive Breast Cancer HER2-negative Breast Cancer Hormone Receptor Positive Tumor Hormone Receptor Negative Tumor Early-stage Breast Cancer Locally Advanced Breast Cancer

Start date: 2022-11-01
Primary completion: 2027-12-31
Enrollment: 716

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.